On the BSE, 460 shares were traded on the counter so far as against the average daily volumes of 1,027 shares in the past one quarter. The stock had hit a high of Rs 725.05 and a low of Rs 690 so far during the day. The stock had hit a 52-week high of Rs 1,110 on 12 September 2016 and a 52-week low of Rs 702.90 on 4 August 2017.
The stock had underperformed the market over the past one month till 4 August 2017, sliding 5.75% compared with the Sensex's 3.57% rise. The stock had also underperformed the market over the past one quarter, declining 8.59% as against the Sensex's 7.3% rise. The scrip had also underperformed the market over the past one year, declining 21.97% as against the Sensex's 16.64% rise.
The small-cap company has equity capital of Rs 7.77 crore. Face value per share is Rs 10.
Shares of TTK Healthcare have tumbled 10.17% in two trading sessions, from its closing of Rs 773.75 on 3 August 2017, after the company during market hours on Friday, 4 August 2017, reported weak Q1 June 2017 results. The stock had slumped 7.05% to settle at Rs 719.20 on Friday, 4 August 2017.
TTK Healthcare reported net loss of Rs 4.48 crore in Q1 June 2017, as compared with net profit of Rs 5.59 crore in Q1 June 2016. Net sales fell 17.9% to Rs 125.37 crore in Q1 June 2017 over Q1 June 2016.
TTK Healthcare has three strategic business units (SBUs) including pharamaceuticals divison, consumer products division and biomedical devices division. Apart from the SBUs, their satellite divisions are foods and maps.
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)